Metrics
Publication
6
Open Access
1
Education
2021 - Present
2021 - PresentExpertise In Medicine
Dokuz Eylul University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
2012 - 2018
2012 - 2018Postgraduate
Azerbaycan Tip Üniversitesi, Faculty of Medicine, Tıp, Azerbaijan
Foreign Languages
B2 Upper Intermediate
B2 Upper IntermediateGerman
B2 Upper Intermediate
B2 Upper IntermediateEnglish
Research Areas
Avesis Research Areas:
Neurology
WoS Research Areas:
Clinical Medicine, Clinical Neurology
Scopus Research Areas:
Neurology (clinical)
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2021 - Present
2021 - PresentResearch Assistant PhD
Dokuz Eylul University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
Articles
All (3)
SCI-E, SSCI, AHCI (3)
SCI-E, SSCI, AHCI, ESCI (3)
Scopus (3)
2026
20261. Real-world transition from uncontrolled disease to stability: Three-year Pre-post natalizumab comparison in relapsing multiple sclerosis
Ozakbas S., Mammadov O., Alizada S., Samadzade U., Caliskan C., Simsek Y.
Multiple Sclerosis and Related Disorders , vol.110, 2026 (SCI-Expanded, Scopus)
2026
20262. No evidence of disease activity after fingolimod treatment: A three-year real-world comparison of pre- and post-treatment outcomes in multiple sclerosis
Samadzade U., Alizada S., Caliskan C., Mammadov O., Ozakbas S.
Multiple Sclerosis and Related Disorders , vol.108, 2026 (SCI-Expanded, Scopus)
2026
20263. Therapeutic Management in an AGRN-Related Congenital Myasthenic Syndrome Patient
Erturk A. Y., Kurt İ., Mammadov O., Sengun İ. Ş.
Journal of Clinical Neurology (Korea) , vol.22, no.1, pp.128-130, 2026 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2026
20261. Real-world effectiveness of ocrelizumab: Altering the six-year disease trajectory in multiple sclerosis
MAMMADOV O., Samadzade U., Alizada S., Caliskan C., Ozakbas S.
12th Congress of the European-Academy-of-Neurology (EAN), Geneva, Switzerland, 27 - 30 June 2026, vol.33, (Summary Text)
2025
20252. Longitudinal Impact of Fingolimod on Disease Course in Multiple Sclerosis: A Three-Year Pre- and Post-Treatment Analysis
Alizada S., Samadzade U., Caliskan C., MAMMADOV O., Ozakbas S.
41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.1249-1250, (Summary Text)
Books
2024
20241. Hyperkinetic Movement Disorders Due to Secondary Causes
Mammadov O., Öztürk V.
in: Current Diagnostic and Therapeutic Approaches to Hyperkinetic Movement Disorders - 2024, Raif Çakmur, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.56-62, 2024
Memberships and Roles in Scientific Organizations
2025 - Present
2025 - PresentEuropean Academy of Neurology
Member
Congress and Symposium Activities
27 June 2026 - 30 June 2026
27 June 2026 - 30 June 202612th Congress of the European Academy of Neurology
Attendee
Geneve-Switzerland
09 May 2026 - 10 May 2026
09 May 2026 - 10 May 2026Symposium on Neuro-Ophthalmology and Neuro-Otology
Attendee
İzmir-Turkey
16 May 2025 - 18 May 2025
16 May 2025 - 18 May 20258th Epilepsy Symposium
Attendee
Muğla-Turkey
13 February 2025 - 16 February 2025
13 February 2025 - 16 February 202522nd Neuropathic Pain Symposium
Attendee
İskele-Cyprus (Kktc)
27 November 2024 - 02 December 2024
27 November 2024 - 02 December 202460th National Neurology Congress
Attendee
Antalya-Turkey
13 November 2024 - 17 November 2024
13 November 2024 - 17 November 202424th National Sleep Medicine Congress
Attendee
Antalya-Turkey
09 November 2024 - 10 November 2024
09 November 2024 - 10 November 20244th Parkinson's Autumn School
Audience
İzmir-Turkey
22 March 2024 - 24 March 2024
22 March 2024 - 24 March 20241st National Headache Congress
Attendee
İstanbul-Turkey
09 March 2024 - 10 March 2024
09 March 2024 - 10 March 2024III. Neurodegenerative Diseases Symposium
Attendee
İstanbul-Turkey
19 May 2023 - 21 May 2023
19 May 2023 - 21 May 2023